NPPA Revises Ceiling Price Of Budesonide (A) +Formoterol (B)

Now, by the present corrigendum NPPA has revised the ceiling price for Budesonide (A) +Formoterol (B). The ceiling price has now been fixed as Rs. 6.95/ per dose. This applies to the dosage in the form of Inhalation (DPI) 400mcg(A) +6 mcg (B).

NPPA Fixes Ceiling Price of New Drugs and Scheduled Formulations

The National Pharmaceutical Pricing Authority (NPPA) has set maximum prices for certain new drug formulations made by specific companies. Additionally, NPPA has also fixed ceiling prices for certain scheduled formulations. The ceiling prices specified are exclusive of GST and apply to the respective dosage forms, strengths, and units detailed in the entries.

Revision In Ceiling Prices Of Coronary Stents

The new ceiling prices are Rs. 10,509.79 per unit for Bare Metal Stents and Rs. 38,267.18 per unit for Drug Eluting Stents (DES). These prices are exclusive of Goods and Services Tax (GST). Manufacturers can revise their existing MRP (Maximum Retail Price) based on the new ceiling price and WPI increase.

NPPA Fixes Ceiling Price of Several Formulations under Drugs (Prices Control) Order, 2013

The manufacturer shall issue a price list in Form–V from date of Notification to NPPA through IPDMS and submit a copy to State Drug Controller and dealers. Every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.

NPPA sets Retail Prices for 19 Formulations

Manufacturers of specific formulations categorized as “new drugs” under the Drug Price Control Order (DPCO), 2013 (DPCO, 2013) are required to set the retail price as indicated in this notification. Manufacturers can add Goods and Services Tax to the retail price only if they have already paid or are liable to pay the government on the mentioned retail price. Manufacturers must issue a price list in Form–V via IPDMS to the National Pharmaceutical Pricing Authority (NPPA) and submit copies to State Drug Controllers and dealers.

NPPA sets Retail Prices for 51 Formulations

The ceiling price for a pack of scheduled formulations should be determined by the concerned manufacturer in accordance with the ceiling price specified. Manufacturers are required to issue a price list in Form-V from the date of notification, as per the Drugs Price Control Order (DPCO), 2013, to the NPPA through IPDMS. A copy of the price list should also be submitted to the State Drug Controller and dealers.